IIA
IPCI

IPG Investment Advisors’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

IPG Investment Advisors’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,050
Closed -$33.1K – 160
2016
Q4 		$33.1K Buy
+1,050
New +$29.3K 0.01% 125

Other funds holding IPCI

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ATC
Argent Trust Co Nashville, Tennessee $2.95B AUM 22.66% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IPG Investment Advisors's IPCI Position: Q1 2017 in Review

IPG Investment Advisors sold out of Intellipharmaceuticals International Inc. (IPCI) in Q1 2017, closing a stake of 1,050 shares — an estimated $33.1K sold.

IPG Investment Advisors first reported a position in IPCI in Q4 2016 and held it in 1 quarter. The position peaked at $33.1K in Q4 2016. 22 funds tracked by Wall St. Rank hold IPCI as of Q1 2017.

  • IPG Investment Advisors reported no remaining Intellipharmaceuticals International Inc. position as of Q1 2017 after selling out during the quarter.
  • IPG Investment Advisors sold 1,050 Intellipharmaceuticals International Inc. shares in Q1 2017, an estimated $33.1K.
  • IPG Investment Advisors first reported a position in Intellipharmaceuticals International Inc. in Q4 2016 and held it in 1 quarter.
  • IPG Investment Advisors's Intellipharmaceuticals International Inc. position peaked at $33.1K in Q4 2016.
  • 22 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q1 2017.

Based on IPG Investment Advisors's 13F filing for Q1 2017, filed 11 May 2017.